JULIE MCCLURE: Open Payments
NPI 1912502717 · BURLINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,543 in 192 payments from 17 companies in 2025. Trend: 2023 $3,700 · 2024 $3,683 · 2025 $3,543
Food & beverage: $3,521Education: $22
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 27 | $527 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $423 |
| Teva Pharmaceuticals USA, Inc. | 14 | $363 |
| Otsuka America Pharmaceutical, Inc. | 19 | $347 |
| ABBVIE INC. | 25 | $346 |
| Neurocrine BioSciences, Inc. | 11 | $283 |
| E.R. Squibb & Sons, L.L.C. | 12 | $225 |
| Lundbeck LLC | 13 | $222 |
| Almatica Pharma LLC | 9 | $169 |
| Janssen Pharmaceuticals, Inc | 7 | $165 |
Products named: ARISTADA, CAPLYTA, VRAYLAR, UZEDY, REXULTI, INGREZZA, COBENFY, LOREEV XR.
Industry payments across NC — which companies pay providers there.
